Literature DB >> 21210137

"Sixteen and a half": a novel pontine neuro-ophthalmological syndrome.

G Cummins, A O'Hare, R Dunne, S Connolly, K O'Rourke, T Lynch.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21210137     DOI： 10.1007/s00415-010-5890-z

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

1.  Eight-and-a-half syndrome: one-and-a-half syndrome plus cranial nerve VII palsy.

Authors:  E Eggenberger
Journal:  J Neuroophthalmol       Date:  1998-06       Impact factor: 3.042

2.  The one-and-a-half syndrome--a unilateral disorder of the pontine tegmentum: a study of 20 cases and review of the literature.

Authors:  M Wall; S H Wray
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

3.  Some neuro-ophthalmological observations.

Authors:  C M Fisher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-10       Impact factor: 10.154

4.  Paramedian pontine infarction. Neurological/topographical correlation.

Authors:  S Kataoka; A Hori; T Shirakawa; G Hirose
Journal:  Stroke       Date:  1997-04       Impact factor: 7.914
  4 in total
  4 in total

Review 1.  Recent advances in the diagnosis and treatment of balance disorders.

Authors:  Klaus Jahn; Marianne Dieterich
Journal:  J Neurol       Date:  2011-10-27       Impact factor: 4.849

2.  'Twenty-four-and-a-half' syndrome and contralateral hemifacial spasm due to pontine carvernoma.

Authors:  Bik Ling Man; Yat Pang Fu
Journal:  BMJ Case Rep       Date:  2014-04-23

3.  One-and-a-half syndrome with its spectrum disorders.

Authors:  Fang Xue; Lihong Zhang; Li Zhang; Zhenguang Ying; Ou Sha; Yan Ding
Journal:  Quant Imaging Med Surg       Date:  2017-12

4.  Sixteen-and-a-half syndrome with metastatic pons tumor: A case report.

Authors:  Shin-Myeong Choi; Tae Gi Kim; Junkyu Chung; Jin-Ho Joo; In-Ki Park; Sang Woong Moon; Jae-Ho Shin
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.